Literature DB >> 29098990

Hodgkin's lymphoma arising in a case of mycosis fungoides: An unusual association.

Preeti Sharma1, Surbhi Goyal1, Amit Kumar Yadav1, Jasmeet Singh2, Ashish Kumar Mandal1.   

Abstract

Mycosis fungoides is a cutaneous T-cell lymphoma with a high risk for developing secondary malignancies, especially B-cell lymphoproliferative disorders. About 40 cases of Hodgkin's lymphoma associated with mycosis fungoides have been reported in literature till date. We report a case of a 35-year-old gentleman who presented with intensely itchy reddish lesions all over the body. Multiple skin biopsies taken from the lesions on scalp and back confirmed the clinical diagnosis of mycosis fungoides. While on treatment, he presented with multiple bilateral cervical, axillary and inguinal lymphadenopathy 9 years after the primary diagnosis of mycosis fungoides. Excision biopsy of a cervical lymph node revealed partial effacement of architecture by a tumor comprising polymorphous background. Histopathology and immunohistochemistry revealed a diagnosis of Hodgkin's lymphoma - nodular sclerosis subtype. The patient was started on chemotherapy for stage IV Hodgkin's lymphoma. Our case emphasizes the importance of keeping secondary Hodgkin's lymphoma in mind while dealing with a patient of mycosis fungoides. Our case immunohistochemically supports the distinct etiopathogenesis of Epstein-Barr virus-negative Hodgkin's lymphoma vis-à-vis cutaneous mycosis fungoides.

Entities:  

Keywords:  Cutaneous; Hodgkin's lymphoma; lymphadenopathy; mycosis fungoides; non-Hodgkin's lymphoma

Mesh:

Year:  2018        PMID: 29098990     DOI: 10.4103/ijdvl.IJDVL_744_16

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  1 in total

1.  The incidences of other primary cancers in patients with mycosis fungoides and Sézary syndrome.

Authors:  Izabela Błażewicz; Berenika Olszewska; Marta Stawczyk-Macieja; Maciej Jaśkiewicz; Roman J Nowicki; Małgorzata Sokołowska-Wojdyło
Journal:  Postepy Dermatol Alergol       Date:  2021-05-22       Impact factor: 1.837

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.